Supplemental material
Acta Oncologica
Volume 60, 2021 - Issue 1
Open access
2,745
Views
19
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship, Rehabilitation and Palliative Care
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
A. H. Boekhouta Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0003-3637-0655View further author information
A. Rogiersb Centre Hospitalier Universitaire Brugmann, Brussels, BelgiumView further author information
, K. Jozwiaka Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;c Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, GermanyView further author information
, M. J. Boers-Sonderend Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The NetherlandsView further author information
, A. J. van den Eertweghe Amsterdam University Medical Centre, Amsterdam, The NetherlandsView further author information
, G. A. Hospersf Department of Medical Oncology, University Medical Centre Groningen, Groningen, The NetherlandsView further author information
, J. W. B. de Grootg Isala Oncology Center, Zwolle, The NetherlandsView further author information
, M. J. B. Aartsh Department of Medical Oncology, Maastricht University Medical Centre, Maastricht, The NetherlandsView further author information
, E. Kapiteijni Leiden University Medical Centre, Leiden,The NetherlandsView further author information
, A. J. ten Tijej Department of Internal Medicine, Amphia Hospital, Breda, The NetherlandsView further author information
, D. Piersmak Medical Spectrum Twente, Enschede,The NetherlandsView further author information
, G. Vreugdenhill Department of Internal Medicine, Maxima Medical Centre, Eindhoven,The NetherlandsView further author information
, A. A. van der Veldtm Erasmus University Medical Centre, Rotterdam, The NetherlandsView further author information
, K. P. M. Suijkerbuijkn Department of Medical Oncology, University Medical Cancer Center, Utrecht, The NetherlandsView further author information
, E. A. Rozemana Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsView further author information
, B. Neynso Universitair Ziekenhuis Brussel, Brussel, BelgiumView further author information
, K. J. Janssenp Bristol-Myers Squibb, Utrecht, The NetherlandsView further author information
, L. V. van de Poll-Fransea Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsView further author information
& C. U. Blanka Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsView further author information
show all
Pages 69-77
|
Received 04 Jun 2020, Accepted 31 Aug 2020, Published online: 14 Sep 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.